Biopsy after ablation: a new way to catch hidden cancer?
NCT ID NCT04143516
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study is testing whether taking a needle biopsy right after a tumor ablation procedure for liver metastases can detect cancer cells that survived the treatment. The results could help doctors decide if more treatment is needed right away. The study also looks at imaging and genetic markers to improve future care. About 200 adults with liver metastases that are small (3 cm or less) and show up on a PET scan are being enrolled.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
What this could lead to
If successful, this could improve how doctors decide on retreatment after liver tumor ablation, potentially leading to better outcomes for patients with liver metastases.
What could go wrong
This is an early-to-mid-stage trial with only 200 participants. The biopsies carry risks like bleeding or infection, and the findings may not apply to all patients or tumor types.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LIVER METASTASES are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-••••
Locations
-
Memorial Sloan Kettering Cancer Center
RECRUITINGNew York, New York, 10065, United States
Contact Phone: •••-•••-••••
Contact
Contact Phone: •••-•••-••••